05/01/2025
7:21 PM | Acrivon Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025
6:07 PM | Acrivon Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
6:26 PM | Acrivon Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2025
7:34 AM | Acrivon Therapeutics (Filer)
| Form ARS | |
04/25/2025
7:30 AM | Acrivon Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
7:32 AM | Acrivon Therapeutics (Filer)
| Form DEFA14A | |
04/21/2025
3:22 PM | Acrivon Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2025
3:32 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:28 PM | Acrivon Therapeutics (Issuer)
Levy Adam D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2025
3:30 PM | Acrivon Therapeutics (Issuer)
Levy Adam D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
8:08 AM | Acrivon Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for ACRV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/27/2025
3:48 PM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
4:15 PM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
3:44 PM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
4:36 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:28 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:31 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:52 PM | Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:53 PM | Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:54 PM | Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:55 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:59 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:04 PM | Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:06 PM | Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:08 PM | Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:10 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:11 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
6:06 AM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:22 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
5:49 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
5:43 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:52 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:53 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:36 AM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
3:20 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
7:29 PM | Acrivon Therapeutics (Subject)
Chione Ltd (Filed by)
| Form SC 13G/A | |
07/10/2024
7:34 PM | Acrivon Therapeutics (Subject)
Chione Ltd (Filed by)
| Form SC 13G/A | |
06/24/2024
4:36 PM | Acrivon Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Man I Turn to In Times Like This (Ad) A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.”
Tilson just released a new prediction that runs counter to what mainstream finance is telling you. Market chaos? Hear Tilson’s take now |
06/24/2024
4:26 PM | Acrivon Therapeutics (Issuer)
BAUM CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
4:27 PM | Acrivon Therapeutics (Issuer)
DiRocco Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
4:27 PM | Acrivon Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
4:28 PM | Acrivon Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:56 PM | Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:58 PM | Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:00 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:02 PM | Acrivon Therapeutics (Issuer)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:03 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:05 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:52 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
5:54 PM | Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:31 AM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
